‘Too elegant to ignore’: Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies

A Canadian biotech creating bioprinted tissue therapeutics for type 1 diabetes, obesity and other endocrine and metabolic disorders has raised $115 million in a Series …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Glenmark agrees to market BeiGene’s oncology medicines in India

Tislelizumab and Zanubrutinib are the oncology medicines of BeiGene, which will be commercialised by Glenmark in India. Credit: T. Schneider / Shutterstock.com. Glenmark Pharmaceuticals subsidiary

May 21, 2024

Study reveals mangos attenuates potential against colon cancer

The chemo-preventive potential of Mangiferin (MF) (mango).

January 10, 2024

FDA adcomm votes unanimously in favor of full approval for Eisai’s new Alzheimer’s drug

The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee on Friday voted 6-0 in favor of fully approving Eisai and Biogen’s Alzheimer’s drug Leqembi

June 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.